Cognitive decline in Alzheimer’s disease (AD) is inevitable, but the rate of this decline varies markedly between patients. Identifying a marker for the rate-of-decline can help in predicting prognosis and allocating resources and charting the course of care with patients and their families. Apolipoprotein E gene (APOE) is an important risk factor for late-onset AD and the presence of the genotype is the most significant genetic risk factor. However, establishing a role for APOE in predicting the rate of decline has proved elusive.
|Number of pages||2|
|Publication status||Published - Mar 2014|
|Event||6th International Conference on Alzheimers Disease and Related Disorders in the Middle East - Istanbul, Turkey|
Duration: 25 Oct 2013 → 27 Oct 2013
|Conference||6th International Conference on Alzheimers Disease and Related Disorders in the Middle East|
|Period||25/10/13 → 27/10/13|